Search Results

You searched for : umifenovir  

	No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
	Glenmark introduces higher strength 400 mg FabiFlu tablets for COVID-19 treatment Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
	Glenmark commences 1000 patients surveillance study ; FabiFlu Glenmark has also completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India... Jul 13
	CSIR and Laxai Sciences partners for COVID clinical trials CSIR and Laxai Sciences to seek regulatory approval for clinical trials on COVID-19 patients using combinations of antiviral and host-directed therapies... Jul 08
	Glenmark receive approval for oral antiviral Favipiravir ; COVID-19 treatment Glenmark is the first pharmaceutical company in India to receive approval for antiviral Favipiravir for mild to moderate covid patients... Jun 20
	Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19 Phase 3 Trials will be carried out at King George’s Medical University, Dr Ram Manohar Lohia Institute and Lucknow Medical College... Jun 19
	Glenmark Pharmaceuticals to start combined antiviral test for Covid-19 cure Glenmark to commence phase 3 clinical trial to test combined efficacy Favipiravir and Umifenovir ... May 26
	Glenmark starts Phase 3 trials on Antiviral drug Favipiravir for treatment of COVID-19 patients in India Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India... May 26
8 Matching result(s) found!

Trending Now
	The Value of Risk Communication in Public HealthOctober 08, 2026
	What Makes a Reliable Health Screening Programme?October 08, 2026
	How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
	Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
	AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
	AI and Patient Consent in India: Who Is Responsible?October 06, 2026
	Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
	Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
	Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
	Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
	Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
	Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
	Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
	Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
	Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
	The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026